[Go]
PubMed | Entrez | Structure | PubChem | Help
PubChem  » Substance Summary
 


cleomiscosin A - Substance Summary (SID 12108)

coumarinolignan derivative from Simaba multiflora and Soulamea soulameoides; structure in first source


Drug and Chemical Information: (Total:1)         

Safety and Toxicology

TOXLINE - Citations to the toxicological literature


Literature

Literature Keyword Mining Tool



Data Source:   

Depositor: KEGG
External ID: C09922

Depositor-Supplied Synonyms: (Total: 3)
Sort:
Cleomiscosin A
C09922
76948-72-6


Properties Computed from Structure:
Molecular Weight386.35212 [g/mol]
Molecular FormulaC20H18O8
XLogP3-AA2.1
H-Bond Donor2
H-Bond Acceptor8
Rotatable Bond Count4
Tautomer Count3
Exact Mass386.100168
MonoIsotopic Mass386.100168
Topological Polar Surface Area104
Heavy Atom Count28
Formal Charge0
Complexity595
Isotope Atom Count0
Defined Atom StereoCenter Count2
Undefined Atom StereoCenter Count0
Defined Bond StereoCenter Count0
Undefined Bond StereoCenter Count0
Covalently-Bonded Unit Count1


Descriptors Computed from Structure:
IUPAC Name: (2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-5-methoxy-2,
3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one
Canonical SMILES: COC1=C(C=CC(=C1)C2C(OC3=C4C(=CC(=C3O2)OC)C=CC(=O)O4)CO)O
Isomeric SMILES: COC1=C(C=CC(=C1)[C@@H]2[C@H](OC3=C4C(=CC(=C3O2)OC)C=CC(=O)O4)CO)O
InChI: InChI=1S/C20H18O8/c1-24-13-7-10(3-5-12(13)22)17-15(9-21)26-20-18-11(4-6-
16(23)27-18)8-14(25-2)19(20)28-17/h3-8,15,17,21-22H,9H2,1-2H3/t15-,
17-/m1/s1

InChIKey: OCBGWPJNUZMLCA-NVXWUHKLSA-N


Substance Information:
SID 12108   
Deposit Date: 2005-06-24
Modify Date: 2008-09-10

CID 442510   
Create Date: 2005-06-24

Related Substances:
Same: 7 Links
Same, Connectivity: 21 Links

Similar Substances: 1506 Links


Depositor-Supplied Comments:
CAS: 76948-72-6
KNApSAcK: C00002984
3DMET: B03381

     
Compound Displayed

2D

3D

Compound ID442510
Molecular Weight386.35212 [g/mol]
Molecular FormulaC20H18O8
XLogP3-AA2.1
H-Bond Donor2
H-Bond Acceptor8


 Write to Helpdesk | Disclaimer | Privacy statement | Accessibility